IPP Bureau
Marengo Asia Hospitals acquires majority stake in Sunshine Global Hospitals
By IPP Bureau - April 18, 2026
Move strengthens footprint in Western India and expands multi-specialty care network
NHA convenes Chintan Shivir to accelerate Ayushman Bharat schemes
By IPP Bureau - April 18, 2026
Focus on preventive, tech-driven healthcare and digital ecosystem reforms under AB PM-JAY and ABDM
ANRF CEO calls for excellence-led innovation at SRMIST Research Day
By IPP Bureau - April 18, 2026
Dr Shivkumar Kalyanaraman emphasizes need for quality research, partnerships, and measurable outcomes
Cipla receives two observations following USFDA inspection at Goa facility
By IPP Bureau - April 18, 2026
The company stated that it will work closely with the regulator to address the observations within the stipulated timeframe
Experts endorse low-sodium salt substitutes to cut India’s hypertension burden
By IPP Bureau - April 18, 2026
Consensus calls for nationwide adoption of potassium-enriched salt to reduce cardiovascular disease risk
Department of Biotechnology invites applications for DBT Research Associateship 2025–26
By IPP Bureau - April 18, 2026
Postdoctoral fellowship aims to build skilled talent pool in biotechnology and life sciences
Department of Pharmaceuticals seeks proposals for SPEL study to strengthen logistics ecosystem
By IPP Bureau - April 18, 2026
Bidding window open till May 15; study to map costs and bottlenecks across pharma supply chains
Danone India backs community-led anaemia screening for 1 lakh children in UP
By IPP Bureau - April 17, 2026
The programme is being implemented in collaboration with Grow Well Foundation and is expected to expand in a phased manner
Salve Group launches Parasoft foot cream to address dry and cracked feet
By IPP Bureau - April 17, 2026
This combination works to break down rough patches, improve moisture retention, and enhance overall skin texture
Syntegon reports record FY25 Results; revenue rises 10% to €1.75 billion
By IPP Bureau - April 17, 2026
The company allocated €56 million to research and development for next-generation line solutions
Kayentis and RWS partner to improve clinical trial data reliability in CNS studies
By IPP Bureau - April 17, 2026
Integrated eCOA technology and rater training aim to reduce variability and strengthen ClinRO outcomes
Revvity aims to accelerate breakthroughs in cancer research
By IPP Bureau - April 17, 2026
Revvity is positioning its technologies as a connected engine for discovery
Bayer flags major Phase III results for stroke prevention drug asundexian
By IPP Bureau - April 17, 2026
The study evaluated asundexian (50 mg), a once-daily oral anticoagulant candidate, versus placebo—both given alongside standard antiplatelet therapy
Piramal Pharma, Ajinomoto Bio-Pharma collaborate to accelerate ADC development
By IPP Bureau - April 17, 2026
Collaboration integrates AJICAP™ technology with global manufacturing capabilities to streamline antibody-drug conjugate pipelines
NIFTY Pharma shows stable trend amid cautious market sentiment
By IPP Bureau - April 17, 2026
Muted movement reflects consolidation phase as investors await earnings triggers
